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a b s t r a c t
Virus manipulation of the ubiquitin–proteasome system has become increasingly apparent. Ubiquitin is
a 76 amino acid protein that is post-translationally conjugated to target proteins, while poly-
ubiquitination subsequently leads to degradation via the 26S proteasome. Target speciﬁcity is determined
by a large family of ubiquitin ligases. Poxviruses encode p28, a highly conserved ubiquitin ligase expressed
in a wide range of poxviruses (J. Virol. 79:597). Here we investigate the relationship between p28 and
ubiquitination. Confocal microscopy indicated that orthologs of p28 co-localized with ubiquitin at the virus
factory. Flow cytometry assays further demonstrated that p28 was regulated by proteasomal degradation.
Moreover, when the ubiquitin ligase activity of p28 was disrupted by mutating the RING domain conjugated
ubiquitin still localized to the viral factories, indicating that an unknown ubiquitin ligase(s) was responsible
for regulating p28. Our observations indicate that p28 is a ubiquitin ligase that is regulated by ubiquitination
and proteasomal degradation.
Crown Copyright & 2014 Published by Elsevier Inc. All rights reserved.
Introduction
The Poxviridae are a large family of dsDNA viruses that replicate
and assemble within the cytoplasm of infected cells (Moss, 1996).
Members of the poxvirus family infect a wide range of hosts that
include both invertebrates and vertebrates (Moss, 1996). Variola
virus, a member of the orthopoxvirus genus is the most notorious
member of the poxvirus family and the causative agent of
smallpox (Moss, 1996). Smallpox was eradicated through an
aggressive vaccination program that used vaccinia virus as the
vaccinating agent (Wehrle, 1980). Aside from the potential health
threats associated with these viruses, much interest in poxvirus
research focuses on virus encoded immune evasion strategies
(Johnston and McFadden, 2003; Mohamed and McFadden, 2009;
Seet et al., 2003).
Members of the poxvirus family are renowned for encoding
multiple immunomodulatory proteins capable of manipulating
immune defences (Johnston and McFadden, 2003; Seet et al.,
2003), and the importance of poxvirus exploitation of the host
ubiquitin–proteasome pathway has become apparent (Barry et al.,
2010; Zhang et al., 2009). Ubiquitin is a highly conserved 76
amino-acid protein that is post-translationally added to lysine
residues on target proteins (Weissman, 2001). The addition of
ubiquitin occurs through a highly conserved enzymatic cascade
that requires activation of ubiquitin by an E1 activating enzyme
followed by the transfer of ubiquitin to an E2 ubiquitin conjugat-
ing enzyme (Weissman, 2001). Speciﬁcity is determined by a large
number of E3 ubiquitin ligases, which mediate the transfer of
activated ubiquitin to protein substrates (Weissman, 2001). Pro-
tein ubiquitination can modify protein function, or more com-
monly, result in protein degradation by the 26S proteasome. Poly-
ubiquitin chains form through any one of seven lysines within
ubiquitin, however, chains typically formed through lysine-48
(K48) target proteins for proteasomal degradation (Pickart and
Fushman, 2004).
Given the importance of the ubiquitin–proteasome pathway it
is not surprising that many viruses have developed multiple
strategies to exploit the host ubiquitination system (Isaacson and
Ploegh, 2009; Randow and Lehner, 2009). Viruses invariably act at
the point of substrate recognition, typically involving the E3
ubiquitin ligase, either by encoding their own ligase or manipulat-
ing a host ligase (Isaacson and Ploegh, 2009; Randow and Lehner,
2009). Several viruses encode proteins that function as substrate
adapters for cullin-based ubiquitin ligases. For example, adeno-
virus virus proteins E4orf6 and E1B55K recruit a cullin-5 based
ubiquitin ligase to degrade p53 (Querido et al., 2001). Similarly,
the Human Papillomavirus E6 protein redirects a cellular HECT
ubiquitin ligase to degrade p53 (Scheffner et al., 1993). Addition-
ally, viruses encode proteins with direct ubiquitin ligase activity.
For example, herpes simplex virus encodes ICP0, a RING ﬁnger
containing ubiquitin ligase that is required for lytic infection and
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reactivation from latency (Everett, 2000). Furthermore, members of
the herpesvirus family regulate levels of cell surface molecules
through the expression of a virus encoded ubiquitin ligase (Coscoy
and Ganem, 2003). Viral manipulation of the ubiquitin–proteasome
system is not limited to protein degradation, as more recently it has
become clear that retroviruses utilize ubiquitin to facilitate virus
budding (Baumgartel et al., 2011; Morita et al., 2011). Importantly,
proteasomal inhibitors effectively interfere with viral replication
further establishing an intricate relationship with the cellular ubi-
quitin–proteasome system (Delboy et al., 2008; Neznanov et al.,
2008; Prosch et al., 2003; Schubert et al., 2000; Yu and Lai, 2005).
The importance of the ubiquitin–proteasome system during
poxvirus infection was highlighted by the observation that pox-
viruses require a functional ubiquitin–proteasome for replication
and expression of late genes (Satheshkumar et al., 2009; Teale
et al., 2009). The genomes of entomopoxviruses and canarypox
virus encode conserved homologs of cellular ubiquitin (Afonso
et al., 1999; Tulman et al., 2004). Studies have demonstrated that
poxviruses encode proteins that manipulate the ubiquitin–protea-
some system; including proteins that function as substrate adap-
ters, and proteins with intrinsic ubiquitin ligase activity
(Mohamed and McFadden, 2009). Myxoma virus, a rabbit speciﬁc
poxvirus, encodes the ubiquitin ligase M153R that downregulates
MHC class I and CD4 from the cell surface (Fruh et al., 2002;
Mansouri et al., 2003). Research in our laboratory demonstrated
that ectromelia virus (ECTV) encodes a novel family of F-box
proteins that interact with the cullin-1 based SCF (Skp1/Cul1/
F-box) complex, and a family of BTB-kelch proteins that interact
with the cullin-3 based ubiquitin ligases (Mohamed et al., 2009;
van Buuren et al., 2008; Wilton et al., 2008). These poxvirus
proteins may function as substrate adapters to potentially redirect
host cellular ligases towards as of yet unknown substrates (Mercer
et al., 2005; Sonnberg et al., 2009, 2008; Wilton et al., 2008).
Poxviruses also encode a highly conserved ubiquitin ligase, p28,
which contains a C-terminal RING-ﬁnger ubiquitin ligase domain and
an N-terminal DNA binding domain, termed KilA-N (Huang et al.,
2004; Iyer et al., 2002; Nerenberg et al., 2005). Our previous work
demonstrated that p28 encoded by vaccinia virus strain IHDW is a
functional ubiquitin ligase that localizes to cytoplasmic regions of virus
replication, referred to as virus factories (Nerenberg et al., 2005). In the
presence of p28, conjugated ubiquitin localizes to virus factories during
vaccinia infection (Huang et al., 2004; Nerenberg et al., 2005).
Furthermore, in vivo studies indicate that p28 is a critical virulence
factor during ectromelia virus infection (Senkevich et al., 1994, 1995).
Given that p28 is an important virulence factor, we investigated the
regulation of p28 during virus infection. Here we show that p28
orthologs localize with conjugated ubiquitin at virus factories. We
further demonstrate that p28 is regulated by proteasomal degradation.
Upon treatment with proteasome inhibitors, p28 was dramatically
stabilized and highly ubiquitinated indicating that p28 is regulated by
ubiquitination and proteasomal degradation. Furthermore, we suggest
that p28 may regulate itself through autoubiquitination. Moreover,
when p28 was disrupted by mutating the RING domain, conjugated
ubiquitin still localized to the viral factories, indicating that an
unknown ubiquitin ligase(s) was responsible. Taken together we
demonstrate that like many cellular ubiquitin ligases, p28 is subjected
to proteasomal degradation and highly regulated by ubiquitination.
Results
p28 orthologs co-localize with conjugated ubiquitin at the virus
factory
Previous studies indicate that p28 encoded by vaccinia virus
(VACV) strain IHDW is a functional ubiquitin ligase that targets
conjugated ubiquitin to the viral factory (Huang et al., 2004;
Nerenberg et al., 2005). p28 orthologs are encoded in a wide
range of poxviruses including VACV(IHDW), ectromelia virus
(ECTV), myxoma virus (MYXV) and fowlpox virus (FWPV). p28
encoded by VACV(IHDW) and ECTV share 95% sequence identity
(Fig. 1). In contrast, p28 encoded by VACV(IHDW) shared only 20%
and 16% sequence identity with the myxoma virus ortholog
M143R, and the fowlpox ortholog, FPV150, respectively (Fig. 1).
Notably, the cysteine and histidine residues critical for ubiquitin
ligase function were highly conserved among the four proteins.
Residues 44–51 within the KilA-N domain that are crucial for DNA
binding and are also similar between the four proteins (Fig. 1) (Iyer
et al., 2002). Given the conservation of p28 throughout the
poxvirus family, we sought to determine whether conjugated
ubiquitin co-localized with other p28 orthologs. HeLa cells were
infected with VACV Copenhagen, VACV-Flag-p28(IHDW), and
VACV-Flag-M143R that expresses the p28 ortholog in myxoma
virus (Fig. 2A). To express the p28 orthologs encoded by ECTV and
FWPV, cells were infected with VACV and transfected with pSC66-
p28(ECTV) or pSC66-Flag-FWPV150 under the control of a pox-
virus promoter (Fig. 2A and B). Cells were stained with DAPI to
visualize both the nucleus and cytoplasmic viral factories, and co-
stained with anti-Flag to visualize p28, M143R, or FPV150. ECTV
encoded p28 was visualized with an antibody speciﬁc for p28
(Fig. 2B a–d) (Senkevich et al., 1995). Using this approach, p28
orthologs from VACV-Flag-p28(IHDW) (Fig. 2A e–h) and ECTV
(Fig. 2B a–d) localized to viral factories. The more distantly related
M143R and FPV150, encoded by myxoma virus and fowlpox virus,
also localized to viral factories (Fig. 2A i–p). Furthermore, FK2
conjugated ubiquitin co-localized to viral factories upon expres-
sion of each of the p28 orthologs (Fig. 2A panel f, j and n and 2B
panel b). As expected, upon VACV infection only a minor accumu-
lation of conjugated ubiquitin was present at the virus factory
(Fig. 2A a–d). Taken together, the data indicated that the accumu-
lation of conjugated ubiquitin at the viral factories is conserved
among close and distant relatives of the p28 family of poxvirus
proteins. We further tested the co-localization of p28 and the p28
myxoma virus orthologue M143R with FK2 in mouse macrophage
cell lines J774 and Raw 264 (Fig. 2C and D). Both p28 and M143R
co-localized with conjugated ubiquitin at the virus factories in
mouse macrophages, similar to the effect seen in HeLa cells. We
continued to use HeLa cells in the following experiments due to
the better transfection efﬁcacy.
p28 is regulated by proteasomal degradation and stabilized
by proteasomal inhibitors
Many cellular ubiquitin ligases are regulated by ubiquitination
and subsequent proteasomal degradation (Deshaies and Joazeiro,
2009; Weissman et al., 2011). Given that p28(IHDW) is a functional
ubiquitin ligase, we employed ﬂow cytometry to determine if p28
was regulated by proteasomal degradation (Fig. 3A) (Huang et al.,
2004; Nerenberg et al., 2005). HeLa cells were transiently trans-
fected with pEGFP, pEGFP-p28(IHDW), or pEGFP-p28(ECTV). EGFP
ﬂuorescence served as a measure of p28 expression. As a marker
for cell viability, cells were also stained with TMRE, a ﬂuorescent
dye incorporated into healthy respiring mitochondria (Metivier et al.,
1998). To determine if p28 was regulated by proteasomal degrada-
tion, cells were treated in the absence or presence of MG132,
a peptide aldehyde that reversibly inhibits the chymotrypsin-like
activity of the proteasome (Lee and Goldberg, 1998). Cells transfected
with EGFP alone displayed little change in the number of EGFP
positive cells in the absence or presence of MG132, indicating that
EGFP was not subjected to degradation via the 26S proteasome
(Fig. 3A panels a and b). In the absence of MG132, both EGFP-p28
(IHDW) and EGFP-p28(ECTV) were expressed at very low levels
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(Fig. 3A panel c and e) indicative of proteasomal degradation,
resulting in the degradation of p28(IHDW) and p28(ECTV)
(Deshaies and Joazeiro, 2009; Itahana et al., 2007; Magniﬁco et al.,
2003; Tang et al., 2006; Weissman et al., 2011). Upon the addition of
MG132, both EGFP-p28(IHDW) and EGFP-p28(ECTV) showed a
dramatic increase in p28 expression, indicating that p28 was
stabilized (Fig. 3A panels d and f). We noted, however, that treatment
with MG132 routinely resulted in enhanced cell death, as seen in the
lower right quadrant (Fig. 3 d and f) (Han et al., 2010). A similar
stabilization of p28 was seen upon treatment with other proteasome
inhibitors, including bortezomib and lactacystin (Lee and Goldberg,
1998). The experiment shown in Fig. 3A was repeated in triplicate
and quantiﬁed in Fig. 3B. Furthermore, whole cell lysates showed a
signiﬁcant increase in EGFP-p28(IHDW) and EGFP-p28(ECTV) protein
levels in the presence of MG132 with no change in the stabilization
of EGFP or β-tubulin (Fig. 3C). The data indicate that p28 expression
is regulated by proteasomal degradation and is stabilized upon
treatment with proteasome inhibitors.
The KilA-N domain plays a critical role in the accumulation
of conjugated ubiquitin at the virus factory
The N-terminus of p28 contains a KilA-N DNA binding domain
(Iyer et al., 2002), and deletions within this domain have been
previously reported to prevent localization of p28 to viral factories
(Brick et al., 1998). Therefore, we sought to determine if the KilA-N
Fig. 1. Alignment of p28 orthologs. p28 protein alignments for vaccinia virus (VACV) strain IHDW, ectromelia strain Moscow (ECTV), myxoma virus strain Lusanne (MYXV),
and fowlpox virus (FWPV) were performed via ClustalW (1.82) (http://www.ebi.ac.uk/clustalW/#) (Chenna et al., 2003). The KilA-N domain is underlined in black and the
RING domain is underlined in gray. Asterisks highlight the conserved cysteines and histidine within the RING domain.
K. Mottet et al. / Virology 468-470 (2014) 363–378 365
domain played a critical role in the co-localization of conjugated
ubiquitin and p28 at the viral factory. To examine the
co-localization of p28 with conjugated ubiquitin, HeLa cells were
infected with VACV and transfected with pSC66-Flag-p28(IHDW),
pSC66-Flag-p28(1–152), containing the KilA-N-only domain,
pSC66-Flag(153–242), containing the RING-only domain or
pSC66-Flag(Δ44–51), missing eight amino acids within the KilA-
N domain (Fig. 4A and B). Cells were stained with DAPI to visualize
the virus factories and co-stained with anti-FK2 and anti-Flag to
visualize conjugated ubiquitin and p28, respectively. As expected,
pSC66-Flag-p28(IHDW) and pSC66-Flag-p28(1–152), each containing
a functional KilA-N domain, localized to the virus factory (Fig. 4B
Fig. 2. p28 orthologs co-localize to the virus factory with conjugated ubiquitin. (A) HeLa cells were infected with VACVCop, VV-Flag-IHDW-p28, or VV-Flag-M143R at an MOI
of 5. To express Flag-FPV150 cells were infected with VACV at an MOI of 5 and co-transfected with pSC66-Flag-FPV150. Cells were ﬁxed and treated with DAPI, to visualize
the nucleus and virus factories, and stained anti-Flag and anti-FK2 to detect conjugated ubiquitin (Fujimuro et al., 1994). (B) HeLa cells were infected with VACV at an MOI of
5 and transfected with pSC66-ECTV-p28. Cells were ﬁxed, stained with DAPI, to visualize the nucleus and virus factories, stained with anti-FK2 to detect conjugated
ubiquitin, and stained with an antibody speciﬁc for p28 (Fujimuro et al., 1994; Senkevich et al., 1994, 1995). (C) J774, or (D) Raw264.7 were infected with VACVCop, VACV-
Flag-IHDW-p28, or VACV-Flag-p28(C173S/C176S), or VACV-Flag-M143R at an MOI of 5. Cells were ﬁxed and treated with DAPI, to visualize the nucleus and virus factories,
and stained anti-Flag and anti-FK2 to detect conjugated ubiquitin.
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panel g and k). In contrast, pSC66-Flag-p28(153–242), containing the
RING-only domain, and pSC66-Flag-p28(Δ44–51), missing eight
amino acids within the KilA-N domain, failed to accumulate at viral
factories and instead were distributed throughout the cell and
nucleus (Fig. 4B panel o and s). The data indicated that the KilA-N
DNA binding domainwas critical for localization to the viral factories,
as previously demonstrated (Brick et al., 1998). Given the obvious
differences in localization, we next determined the presence of
conjugated ubiquitin at the factory. Conjugated ubiquitin was
enriched at the virus factory upon expression of Flag-p28 (Fig. 4B
panel f). Signiﬁcantly, pSC66-Flag-p28(1–152), containing only the
KilA-N domain, failed to accumulate signiﬁcant amounts of conju-
gated ubiquitin at the virus factory, even though pSC66-Flag-p28
(1–152) localized predominantly to the virus factory (Fig. 4B panel j).
Expression of the RING-only domain, pSC66-Flag-p28(153–242), was
distributed throughout the cytoplasm, with a minor enrichment of
ubiquitin at the virus factory (Fig. 4B panel n). Expression of Flag-p28
(Δ44–51), missing residues within the KilA-N domain, also lacked
accumulation of conjugated ubiquitin at the virus factory (Fig. 4B
panel r). Overall, the data indicated that wildtype p28 co-localized to
virus factory with conjugated ubiquitin, whereas the p28 mutants
failed to accumulate ubiquitin at the virus factory (Fig. 4B).
To determine if the KilA-N or RING domain were regulated by
the proteasomal degradation, HeLa cells were transiently trans-
fected with EGFP, EGFP-p28, EGFP-p28(1–152), EGFP-p28(153–
242) or EGFP-p28(Δ44–51) (Fig. 4C), and cells were mock-
treated or treated with MG132. As expected, EGFP-p28 expression
was substantially increased in the presence of MG132 (Fig. 4C
panels c and d) and all three deletion mutants showed an increase
in protein expression upon MG132 treatment (Fig. 4C panel f, h, and
j), indicating that all three p28 mutants were stabilized. The data
shown in Fig. 4D were repeated in triplicate and graphed as the
number of EGFP positive cells.
To further investigate the role of ubiquitination during infec-
tion, HeLa cells were infected with a VACV strain, which is
overexpressing HA-tagged ubiquitin (VACV-HA-Ub) and trans-
fected with pSC66-Flag-p28(IHDW), pSC66-p28(1–152), contain-
ing the KilA-N-only domain, pSC66-p28(153–242), containing the
RING-only domain, or pSC66-p28(Δ44–51), missing eight residues
within the KilA-N domain. Ubiquitination was detected by blotting
with anti-Flag and anti-HA in the presence and absence of MG132
(Fig. 5A). Signiﬁcantly, pSC66-Flag-p28(IHDW), pSC66-p28
(1–152), pSC66-p28(153–242) and pSC66-p28(Δ44–51) demon-
strated that all four proteins were highly ubiquitinated upon
treatment with MG132 (Fig. 5A). Despite obvious differences in
viral factory localization (Fig. 4B panel g, k, o and s), all four
proteins were ubiquitinated (Fig. 5A).
RING domain mutants stabilize p28
Since p28 is tightly controlled by proteosomal degradation
(Fig. 3A panel c) and many ubiquitin ligases regulate themselves
through autoubiquitination (Chaugule et al., 2011; Deshaies and
Joazeiro, 2009; Dueber et al., 2011), we sought to determine the
role of the RING domain. Therefore, we generated three p28 RING
mutants (Nerenberg et al., 2005), pEGFP-p28(C173S/C176S),
Fig. 3. p28 is stabilized upon proteasomal inhibition. (A) HeLa cells were transfected with pEGFP, pEGFP-p28(IHDW) or pEGFP-p28(ECTV) for 16 h and treated with or
without 10 mM MG132 for 6 h. Cells were stained with TMRE and EGFP ﬂuorescence was assayed via ﬂow cytometry. (B) The number of EGFP positive cells in (A) were
quantiﬁed in triplicate in the presence and absence of MG132. (C) HeLa cells transfected with pEGFP, pEGFP-p28(IHDW) and pEGFP-p28(ECTV) in the presence and absence
of 10 mM MG132. Whole cells lysates were collected and western blotted with anti-GFP and anti-β-tubulin.
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containing two point mutations critical for ubiquitin ligase func-
tion, pEGFP-p28(1–184), a truncated version lacking the majority
of the RING domain, and pEGFP-p28(1–204), lacking amino acids
205–242 of the RING domain, thereby disrupting the ubiquitin
ligase activity of p28 (Fig. 6A) (Nerenberg et al., 2005). Each of the
three mutant proteins were analyzed for expression in the
presence or absence of MG132 via ﬂow cytometry (Fig. 6B). As
shown previously, EGFP expression was unaltered upon MG132
treatment (Fig. 6B panel a and b), while EGFP-p28(IHDW) was
regulated
by proteasomal degradation and was stabilized upon the addition
of MG132 (Fig. 6B panels c and d). In the absence of MG132,
Fig. 4. The KilA-N DNA binding domain plays a critical role in p28 localization to the virus factory. (A) A schematic of wild type p28 and mutant versions of p28. The KilA-N
DNA binding domain is highlighted in black and the RING domain is shown in white. (B) HeLa cells were infected with VACV at an MOI of 5 and transfected with pSC66-Flag-
p28, pSC66-Flag-p28(1–152), pSC66-Flag-p28(153–242) and pSC66-Flag-p28(Δ44–51). Cells were ﬁxed, stained with DAPI, and p28 was detected by anti-Flag, and
conjugated ubiquitin was detected by anti-FK2. (C) HeLa cells were transfected with pEGFP-p28(1–152), pEGFP-p28(153–242) or pEGFP-p28(Δ44–51) for 16 h and treated
with or without 10 mM MG132 for 6 h. EGFP ﬂuorescence was assayed in triplicate via ﬂow cytometry, and the number of cells is indicated in the upper right quadrant.
(D) The number of EGFP cells were quantiﬁed in triplicate in the presence and absence of MG132.
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EGFP-p28(C173S/C176S), EGFP-p28(1–184), and EGFP-p28(1–204)
were stabilized due to mutagenesis (Fig. 6B panels e, g and i), and
were further stabilized upon MG132 treatment (Fig. 6B panels f, h,
and j), indicating that wild type p28 was regulated by autoubi-
quitination (Fig. 6B panel c and d). The data shown in Fig. 6B was
repeated in triplicate and graphed as the number of GFP expres-
sing cells in Fig. 6C. The data indicated that mutation of the RING
domain resulted in increased stabilization of the RING proteins,
further suggesting that wild type p28(IHDW) uses its RING domain
to regulate itself by autoubiquitination.
An additional ubiquitin ligase promotes the accumulation
of conjugated ubiquitin at the virus factory
Since p28(IHDW) is regulated by proteasomal degradation and
autoubiquitination (Fig. 6), we sought to determine if conjugated
ubiquitin localized to viral factories in the presence of the RING
mutants (Fig. 7). HeLa cells were mock-infected or infected with
VACV and transfected with pSC66-Flag-p28(IHDW), pSC66-Flag-
p28(C173S/C176S), pSC66-Flag-p28(1–184) and pSC66-Flag-p28(1–
204). As expected, conjugated ubiquitin co-localized with pSC66-
Flag-p28(IHDW) at the viral factory (Fig. 7 panels i–l). Conjugated
ubiquitin was still present at the virus factory when pSC66-Flag-p28
(C173S/C176S) was expressed (Fig. 7 panels m–p), suggesting that
an additional ubiquitin ligase was responsible since Flag-p28
(C173S/C176S) lacks intrinsic ubiquitin ligase activity (Nerenberg
et al., 2005). Similarly, conjugated ubiquitin was also present at the
viral factory upon expression of pSC66-Flag-p28(1–204) (Fig. 7
panels u–x). In contrast, little ubiquitin was detected at the virus
factories with pSC66-Flag-p28(1–184) (Fig. 7 panels q–t), suggesting
that the region between amino acids 184 and 204 may be critical for
the ubiquitination of p28. The data indicated that at least one
unknown additional ubiquitin ligase is responsible for the presence
of conjugated ubiquitin at viral factories.
To further investigate the ubiquitination pattern of the p28 RING
mutants, we infected HeLa cells with VACV and transfected cells
with pSC66-Flag-p28(IHDW), pSC66-p28(C173S/C176S), pSC66-p28
(1–184) and pSC66-p28(1–204) in the absence and presence of
MG132, and ubiquitination was detected by blotting with anti-Flag
(Fig. 8A and B). Signiﬁcantly, pSC66-Flag-p28(IHDW), pSC66-p28
(C173/176S), pSC66-p28(1–184) or pSC66-p28(1204) demon-
strated obvious ubiquitination upon treatment with MG132
(Fig. 8A). The ubiquitination pattern of pSC66-Flag-p28(IHDW)
and pSC66-Flag-p28(C173/176S) exhibited a strong ubiquitin ladder
in the presence of MG132, in contrast, pSC66-Flag-p28(1–184)
showed the least amount of ubiquitination upon treatment with
MG132 (Fig. 8A), whereas pSC66-Flag-p28(1–204) demonstrated an
increase in ubiquitination. Overall, these observations are in agree-
ment with the confocal data in Fig. 7 indicating that Flag-p28
(1–184) is unable to detect ubiquitination at the virus factory.
We performed an in vitro ubiquitination assay to demonstrate the
E3 ligase activity or catalytic loss of the p28 mutants and that the
ubiquitination of p28 mutants is not due to rest-ubiquitin ligase
activity. Cells were infected with VACVCop, transfected with pSC66-
Flag-p28, pSC66-Flag-p28(1–152), pSC66-Flag-p28(153–242), pSC66-
Flag-p28(Δ44–51), pSC66-Flag-p28(C173S/C176S), pSC66-Flag-p28
Fig. 5. p28 is regulated by ubiquitination. (A) To detect ubiquitination, HeLa cells (2106) were infected with VACV-HA-Ub and transfected with pSC66-Flag-p28, pSC66-
Flag-p28(1–152), pSC66-Flag-p28(153–242) and pSC66-Flag-p28(Δ44–51). Cells treated with or without MG132 (10 μM) for six hours were lysed in RIPA buffer and p28
constructs were immunoprecipitated with mouse anti-Flag M2 and western blotted with rabbit anti-Flag to detect ubiquitination. (B) Whole cell lysates were harvested and
western blotted with anti-Flag and anti-beta-tubulin as a loading control.
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(1–184), or pSC66-Flag-p28(1–204) and were subjected to immuno-
precipitation using an anti-Flag antibody. The resulting immuno-
complexes were immobilized on Protein G beads, and were used as
the source of ubiquitin ligase and tested in an in vitro ubiquitination
assay. The formation of ubiquitin conjugates was detected by
western blotting for biotinylated ubiquitin adducts. Cell lysates
stained with rabbit anti-Flag showed the presence of all Flag
immunoprecipitated proteins. We previously demonstrated the
ubiquitin ligase activity of p28 in an in vitro ubiquitination assay;
at the same time we showed that the double cysteine mutant p28
(C173S/C176S) lost its ubiquitin ligase activity. Immuncomplexes
generated from infected/transfected cells expressing Flag-p28, and
p28 mutants containing an intact RING domain Flag-p28(153–242),
and Flag-p28(Δ44–51) showed the presence of both free ubiquitin,
as well as high molecular weight ubiquitin conjugates (Fig. 9). These
high molecular weight ubiquitin conjugates were absent in the p28
double cysteine mutants and p28 mutants, which are lacking the
RING domain (pSC66-Flag-p28(1–152)), or have truncated versions
of the RING domain (pSC66-Flag-p28(1–184) and pSC66-Flag-p28(1–
204)) (Fig. 9). This conﬁrms that an intact RING domain is crucial for
ubiquitin ligase activity in p28, suggesting another ubiquitin ligase is
acting on p28.
K48-linked and K63-linked ubiquitin localize to viral factories with
p28 orthologs
Ubiquitin chains formed through lysine-48 (K48) of ubiquitin
are associated with targeting proteins for proteasomal degrada-
tion, while lysine-63 (K63) can act as scaffolds to mediate signal
transduction, or alternate the subcellular localization of the target
protein (Deshaies and Joazeiro, 2009; Komander, 2009; Weissman,
2001). Huang et al. (2004) has previously shown that p28 can
catalyze the formation of K63-linked ubiquitin chains. Since p28 is
regulated by proteasomal degradation and co-localizes with con-
jugated ubiquitin at virus factories, we sought to determine if K48
ubiquitin linkages were present at the viral factories.
Therefore, we generated a HA-Ub-K48 construct under the
control of a T7 promoter, which lacks all lysines residues, except
for lysine-48 allowing ubiquitin chains to be formed only at
position 48 in ubiquitin (Deng et al., 2000). Respectively, we
generated a HA-Ub-K63 construct, which lacks all lysine residues,
except for lysine-63. HeLa cells were infected with VVT7, which
expresses the T7 polymerase under the control of IPTG inducible
promoter (Fuerst et al., 1987), and transfected with HA-Ub, or HA-
K48-Ub, and transfected with pSC66-Flag-p28(IHDW), pSC66-
Flag-M143R, or pSC66-p28(ECTV). Cells were stained with DAPI
to visualize the viral factories, and anti-HA was used to detect
ubiquitin. Upon infection and transfection, both HA-Ub and,
HA-K48-Ub, were found diffuse throughout the cytoplasm
(Fig. 10 panels b and f). However, in the presence of HA-Ub or
HA-K48-Ub, pSC66-Flag-p28(IHDW) (Fig. 10A panels j and n),
pSC66-Flag-M143R (Fig. 10A panels r and v), or pSC66-p28(ECTV)
(Fig. 10B panels b and f) demonstrated ubiquitin at the virus
factory. Similar to pSC66-Flag-p28, pSC66-Flag-p28(C173S/C176S)
also targeted HA-Ub and HA-Ub-K48 to the virus factory (Fig. 11
panels a–h). Furthermore, HeLa cells were infected with VVT7 and
transfected with HA-K63-Ub, and transfected with pSC66-Flag-
p28(IHDW), or pSC66-Flag-p28(C173S/C176S). Cells were stained
Fig. 6. Mutations in the RING domain stabilize p28. (A) Schematic representation of the p28 RING mutants. (B) HeLa cells were transfected with pEGFP-p28(C173S/C176S),
pEGFP-p28(1–184) or pEGFP-p28(1–204) for 16 h and treated with or without 10 mM MG132 for 6 h. (C) The number of EGFP cells were quantiﬁed in triplicate in the
presence and absence of MG132.
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with DAPI, anti-HA and anti-p28. HA-K63-Ub was found diffuse
throughout the cytoplasm (Fig. 11A panel b). However, both
pSC66-Flag-p28 and pSC66-Flag-p28(C173S/C176S) targeted HA-
Ub-K63 to the virus factory (Fig. 11C panels a–h). Taken together
the data indicated that p28(IHDW), M143R and p28(ECTV) pro-
moted the enrichment of K48-ubiquitin at the virus factories and
that this function is conserved amongst members the poxvirus
family.
Discussion
Poxviruses survive and replicate within host cells through the
manipulation of cellular pathways (Johnston and McFadden, 2003;
Seet et al., 2003). Recently, poxvirus manipulation of the host
ubiquitin–proteasome system has become increasingly apparent
(Zhang et al., 2009). Since the ubiquitin–proteasome system plays
an important role in cellular homeostasis, many viruses have
Fig. 7. RING mutants localize to virus factories with conjugated ubiquitin. (A) HeLa cells were mock infected or infected with VACV at an MOI of 5 and transfected with
pSC66-Flag-p28, pSC66-Flag-p28(C173S/C176S), pSC66-Flag-p28(1–184), or pSC66-Flag-p28(1–204). Cells were ﬁxed, stained with DAPI, to visualize the nucleus and
cytoplasmic virus factories, and stained anti-FK2 and anti-Flag to detect conjugated ubiquitin and p28 protein expression, respectively.
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evolved strategies to regulate the process of ubiquitination to their
own advantage, and poxviruses are no exception (Isaacson and
Ploegh, 2009; Randow and Lehner, 2009). Recent evidence indi-
cates that poxviruses encode a family of BTB/kelch proteins and
ankyrin/F-box proteins that likely function as substrate adapters
for cellular cullin-3 and cullin-1 based ubiquitin ligases (Chang
et al., 2009; Johnston et al., 2005; Meng and Xiang, 2006; Mercer
et al., 2005; Mohamed et al., 2009; Mohamed et al., 2009; Sonnberg
et al., 2008; Sperling et al., 2008; van Buuren et al., 2008; Werden
et al., 2009; Wilton et al., 2008). Additionally, poxviruses have also
been shown to encode proteins with intrinsic ubiquitin ligase
activity (Huang et al., 2004; Nerenberg et al., 2005). These include
M153R, a membrane associated RING-CH ubiquitin ligase encoded
by myxoma virus, and p28, a RING encoded ubiquitin ligase
(Huang et al., 2004; Mansouri et al., 2003; Nerenberg et al.,
2005). p28 is a highly conserved ubiquitin ligase that has been
shown to be a critical virulence factor (Huang et al., 2004;
Nerenberg et al., 2005; Senkevich et al., 1994; Senkevich et al.,
1995). We previously demonstrated that VACV-IHDW p28 and
M143R were auto-ubiquitinated in vitro and that both ligases
localized to viral factories independent of their ligase activity
(Nerenberg et al., 2005). Here we further investigate the regulation
of p28.
In addition to p28(IHDW), other poxvirus encode p28-like
ubiquitin ligases. For example, p28 is conserved throughout the
Orthopoxviridae and both p28(IHDW) and p28(ECTV) co-localized
to the virus factory with conjugated ubiquitin (Fig. 2). Additionally,
distantly related p28 proteins are found in other genera, including
M143R encoded by myxoma virus, and FWPV150 encoded by
fowlpox virus (Afonso et al., 2000; Cameron et al., 1999). Despite
the lower sequence identity compared to p28-IHDW, both M143R
and FPV150 co-localized with conjugated ubiquitin at the virus
factory indicating that p28 function is highly conserved among
members of the poxvirus family (Fig. 2). Our data indicate that
localization of p28 at the viral factories was dependent on the
KilA-N DNA binding domain (Fig. 4) that is found in bacteria,
bacteriophage and large DNA viruses (Brick et al., 1998; Iyer et al.,
2002). Interestingly, multiple KilA-N DNA domain containing
proteins are found in both fowlpox and canarypox (Afonso et al.,
2000; Tulman et al., 2004). However, only two proteins in fowlpox
and canarypox virus are paired with a RING domain, and the
remainder of the KilA-N domains are associated with “domains of
unknown function” or KilA-N-only domains. The function of these
latter proteins is currently unknown (Afonso et al., 2000; Tulman
et al., 2004).
Since many cellular and viral ubiquitin ligases are regulated
through ubiquitination and autoubiquitination, we investigated
the regulation of p28 (Deshaies and Joazeiro, 2009). We used a
ﬂow cytometry assay to determine if p28 was regulated by the
proteasome. In the absence of a proteasome inhibitor, both EGFP-
p28(IHDW) and EGFP-p28(ECTV) were expressed at low levels
(Fig. 3 panel c and e), suggesting that p28 is likely regulated by
Fig. 8. p28 RING mutants demonstrate variable patterns of ubiquitination. (A) To detect ubiquitination, HeLa cells (2106) were infected with VACV and transfected with
pSC66-Flag-p28, pSC66-Flag-p28(C173S/C176S), pSC66-Flag-p28(1–184), and pSC66-Flag-p28(1–204). Cells treated with or without MG132 (10 μM) for six hours were lysed
in RIPA buffer and p28 constructs were immunoprecipitated with mouse anti-Flag M2 and western blotted with rabbit anti-Flag to detect ubiquitination. (B) Whole cell
lysates were harvested and western blotted with anti-Flag and anti-beta-tubulin as a loading control.
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autoubiquitination, providing a means by which ubiquitin ligases
regulate themselves (Deshaies and Joazeiro, 2009). However,
stabilization, via inhibition of the proteasome, indicated that both
p28(IHDW) and p28(ECTV) were signiﬁcantly stabilized upon
MG132 treatment (Fig. 3A panels a–f). The data indicate that p28
is regulated by proteasomal degradation and co-localizes with
conjugated ubiquitin at the virus factory, whereas, mutant version
of p28 demonstrate little ubiquitin at the virus factory (Figs. 4B
and C). However, in the presence of MG132 all four proteins
showed obvious ubiquitin ladders indicating that p28, p28(1–152),
p28(153–242) and p28(Δ44–51) are ubiquitinated (Fig. 5A).
Given that our data indicated that p28 was tightly controlled by
proteasomal degradation, we examined three p28 RING mutants
for their ability to be stabilized (Fig. 6B). In the absence of MG132,
expression of all three of the RING mutants examined showed
signiﬁcant stabilization compared to wildtype p28 (Fig. 6B panels
a, c, e, g and i), suggesting that RING domain of p28 plays a role in
ubiquitinating itself leading to subsequent degradation via the
proteasome. A large number of ubiquitin ligases are known to be
autoubiquitinated in order to regulate themselves (Deshaies and
Joazeiro, 2009; Weissman et al., 2011). For example, Mdm2 and
Cbl are known to mediate their own degradation through auto-
ubiquitination (Magniﬁco et al., 2003; Tang et al., 2006). Similar to
p28, mutating the RING domain of Mdm2 inhibits ubiquitin ligase
activity stabilizing Mdm2 (Deshaies and Joazeiro, 2009). Impor-
tantly, upon MG132 treatment, we found that all three of the p28
RING mutants were further stabilized (Fig. 5B panels b, d, f, h and j).
Similar to p28, Mdm2 stability is also regulated by other ubiquitin
ligases, an event that appears to be common within the ubiquitin–
proteasome pathway (Itahana et al., 2007). Confocal images demon-
strated conjugated ubiquitin at the virus factories in the presence of
Flag-p28(C173S/C176S) and Flag-p28(1–204) (Fig. 7 panels n and v).
All three of the RING mutants lacked intrinsic ubiquitin ligase
activity (Fig. 9), indicating that the conjugated ubiquitin present
at the factory was due to the activity of another ubiquitin ligase.
As previously observed, conjugated ubiquitin failed to co-localize
with Flag-p28(1–184) at the virus factory (Fig. 7 panel r) (Nerenberg
et al., 2005). Potentially, Flag-p28(1–184) is no longer capable of
interacting with the E2 conjugating enzyme that is required for
ubiquitination and mutations within RING domains have been
shown to disrupt E2–E3 interactions (Deshaies and Joazeiro,
2009). In fact, it appears that p28(1–184) demonstrated only minor
amounts of ubiquitination (Fig. 8A). The data suggests that p28 is a
dually regulated ubiquitin ligase, which regulates itself through
autoubiquitination in addition to being regulated by another
ubiquitin ligase or ligases. Identiﬁcation of this unknown ubiquitin
ligase would provide further insight into the regulation of p28.
The role of ubiquitination has been growing in complexity since
ubiquitin can modify protein function, target proteins for degrada-
tion, depending on the type of ubiquitin chains formed on target
proteins (Komander, 2009; Pickart and Fushman, 2004). Typically,
ubiquitin chains formed through K48 of ubiquitin, target proteins
for degradation via the proteasome (Komander, 2009; Pickart and
Fushman, 2004). We observed that expression of K48-Ub in the
context of virus infection resulted in the enrichment of K48-Ub at
the virus factory (Fig. 10A and B). This indicated that p28 function
is conserved across members of the poxvirus family, recruiting p28
and ubiquitin to the viral factory. Expression of wild type p28
resulted in the dramatic accumulation of conjugated ubiquitin at
the viral factory, suggesting that p28 itself, or currently unidenti-
ﬁed substrates, are responsible for the accumulation of conjugated
ubiquitin at the factory (Fig. 7 panel j). Identiﬁcation and char-
acterization of both cellular and viral protein substrates targeted
by p28 will be the focus of future studies. One of the ﬁrst described
poxviral E3 ligases is M153R found in myxomavirus, a poxviral
strain infecting rabbits (Fruh et al., 2002; Mansouri et al., 2003).
M153R is a membrane-associated RING-CH (MARCH) E3 ligase.
MARCH has a modiﬁed RING domain at its N-terminus combined
with a transmembrane domain, which remains it localized at the
membrane down-regulating cell surface immune molecules like
MHC class I, MHC Class II, or CD4 dampening the immune
response (Fruh et al., 2002; Mansouri et al., 2003). Herpes Simplex
Virus (HSV) encodes a RING ﬁnger ubiquitin ligase, called ICP0.
ICP0 ubiquitinates cellular proteins and is an important mediator
for reactivation of HSV from its latent state to lytic infection
(Everett, 2000). Kaposi's Sarcoma-Associated Herpesvirus encodes
viral E3 ligases K3 and K5 that are responsible for immune evasion
strategies targeting numerous host cell response factors. These
include amongst others ICAM-1 (Ishido et al., 2000; Coscoy and
Ganem, 2001), MHC class I antigen presentation (Coscoy and
Ganem, 2000; Ishido et al., 2000; Haque et al., 2001; Stevenson
et al., 2000), or PECAM-1 (Mansouri et al., 2006). Determining
how and why p28 regulates its protein substrates during virus
infection will undoubtedly provide information regarding pox-
viruses and the ubiquitin-proteasome system. Given that p28
possesses a KilA-N domain, which is critical for p28 localization
to virus factories (Fig. 4), it is tempting to speculate that p28 plays
a critical role in ubiquitinating proteins at the virus factory.
Additionally, p28 is expressed early during infection, prior to viral
factory formation, suggesting that at early times p28 may be
ubiquitinating other proteins (Senkevich et al., 1994, 1995). Buller
and colleagues have shown that p28 is a critical virulence factor
(Senkevich et al., 1994). Lack of virulence in the p28 knock out
virus is due to the inability of ECTV to replicate in macrophages of
infection mice (Senkevich et al., 1994, 1995). Attenuated pox-
viruses, such as VACV strain Copenhagen and Western Reserve,
contain deleted or truncated versions of p28, suggesting that p28
plays an important role in virulent viruses (Goebel et al., 1990).
Fig. 9. In vitro ubiquitin ligase activity of p28 and p28 mutants. Protein G beads
containing Flag tagged proteins were mixed in an in vitro ubiquitination reaction
with E1, (E2), ATP, and biotin-labeled ubiquitin (BIOMOL International). Reactions
were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
were probed with streptavidin-taggen HRP. Western blotting shows the appearance
of high-molecular mass ubiquitin adducts in reactions containing either p28, or p28
mutants containing the RING domain.
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Fig. 10. p28 orthologs co-localize with HA-Ub and HA-K48-Ub. (A) HeLa cells were infected with VVT7 at MOI of 5 for one hour. Cells were co-transfected with either pBS-
HA-WT-Ub, pBS-HA-K48-Ub, and either pSC66-Flag-IHDW-p28, or pSC66-Flag-M143R as indicated. Cells were treated with 10 mM IPTG for 16 h, ﬁxed and stained with
DAPI, to visualize the viral factories and nucleus. Anti-HA and anti-Flag detected the presence of ubiquitin, p28 and M143R, respectively. (B) Similar to (A) HeLa cells were
infected with VVT7 at MOI of 5 for one hour and cells were co-transfected with pBS-HA-WT-Ub or pBS-HA-K48-Ub and pSC66-ECTV-p28. Cells were treated with 10 mM
IPTG for 16 h, ﬁxed and stained with DAPI, anti-HA and anti-Flag, to visualize ECTV-p28.
K. Mottet et al. / Virology 468-470 (2014) 363–378374
Materials and methods
Cells and viruses
HeLa cells, J774 and Raw 264 cells were obtained from Amer-
ican Type Culture Collection, and grown in Dulbecco's Modiﬁed
Eagle Medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), 50 U of penicillin/mL, 50 μg of streptomycin/mL and
200 μM glutamine (Invitrogen). Baby Green Monkey Kidney
(BGMK) cells were obtained from the American Type Culture
Collection, grown in DMEM containing 10% New Born Calf Serum,
50 U of penicillin/mL, 50 μg of streptomycin/mL and 200 μM
glutamine (Invitrogen). Vaccinia virus strain Copenhagen (VACV-
Cop) was provided by G. McFadden (University of Florida,
Gainesville, FL). Recombinant VACV-Flag-M143R, Recombinant
VACV-HA-Ubiquitin and VACV-Flag-p28(IHDW) were previously
described (Nerenberg et al., 2005). VACV strain Western Reserve
expressing T7 polymerase and VVT7lacOI (VVT7) was a generous
gift from B. Moss (National Institute of Allergy and Infectious
Diseases, Bethesda) (Fuerst et al., 1987). All viruses were propagated
in BGMK cells and puriﬁed as previously described (Stuart et al.,
1991).
Alignments
Protein alignments for p28 in vaccinia virus strain IHDW,
ectromelia strain Moscow (ECTV), myxoma virus strain Lusanne
(MYXV), and fowlpox virus (FWPV) were performed via Clustral W
(1.82) (http://www.ebi.ac.uk/clustalW/#) (Chenna et al., 2003).
Plasmids
To maximize expression of p28 in mammalian cells, p28(IHDW)
was codon optimized by GeneArt (Regensburg, Germany). p28
(IHDW) and p28(ECTV) were subcloned into pEGFP-C3. Versions of
p28 included EGFP-p28(1–152), EGFP-p28(153–242), EGFP-p28
(Δ44–51), EGFP-p28(1–204), EGFP-p28(1–184), and EGFP-p28
(C173S/C176S) were subcloned into pEGFP-C3. pSC66 containing
a synthetic poxvirus early/late promoter was provided by
Dr. B. Moss (National Institute of Infectious Diseases, Bethesda).
Fig. 11. p28(C173S/C176S) co-localizes with HA-Ub, HA-K48-Ub and HA-K63 at the viral factories. HeLa cells were infected with VVT7 at MOI of 5, and cells were
co-transfected with either (A) pBS-HA-WT-Ub or pBS-HA-K48-Ub, and pSC66-Flag-p28(C173S/C176S), or (B and C) pBS-HA-WT-Ub or pBS-HA-K63-Ub, and pSC66-Flag-p28,
or pSC66-Flag-p28(C173S/C176S). Cells were treated with 10 mM IPTG for 16 h, ﬁxed and stained with DAPI, to visualize the viral factories and nucleus. Anti-HA detected
HA-Ub, HA-K48-Ub, and HA-K63-Ub and anti-p28 detected the presence of Flag-p28 and Flag-p28(C173S/C176S).
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pSC66-Flag-p28(IHDW) and pSC66-Flag-M143R were previously
described (Nerenberg et al., 2005), and Flag-FPV150 was sub-
cloned into pSC66 to generate FPV-Flag-FPV150. Flag-p28(1–152),
Flag-p28(153–242), Flag-p28(Δ44–51), Flag-p28(1–204), Flag-p28
(1–184), and Flag-p28(C173S/C176S) were subcloned into pSC66
for expression during poxvirus infection (Earl et al., 2001). Ectro-
melia virus encoded p28 was ampliﬁed from viral DNA and
subcloned into pSC66 for expression during poxvirus infection.
J. Hiscott provided pcDNA3-HA-Ub (McGill University, Montreal,
Canada) and Z. Chen provided pEF-HA-K48-Ub and pEF-HA-K63-
Ub (University of Texas, Southwestern Medical Center, Dallas, TX).
HA-Ub, HA-K48-Ub and HA-K63-Ub were subcloned into pBlue-
Script. All constructs were veriﬁed by sequencing at the Applied
Genomics Center at the University of Alberta.
Infection/transfection
HeLa cells (5105) were infected with VACV at a multiplicity of
infection (MOI) of 5. Cells were subsequently transfected with 2 μg
of pSC66-based plasmids and 2 μL Lipofectamine 2000 (Invitro-
gen). Following 2 h of infection/transfection 1 mL of DMEM con-
taining 20% FBS and 200 μM glutamine was added to the cells.
Confocal microscopy
HeLa cells (5105) were seeded on 18 mm cover slips and
infected at a multiplicity of infection (MOI) of 5 and transfected
with Lipofectamine 2000 (Invitrogen). Cells were infected with
VACV and stained with DAPI, anti-Flag(M2) (Sigma-Aldrich), and
anti-FK2 (Enzo Life Sciences) to determine Flag expression and FK2
localization at the virus factory (Fujimuro et al., 1994). Coverslips
were washed with phosphate-buffered saline (PBS) containing 1%
FBS and mounted in 4 mg/mL of N-propyl gallate (Sigma-Aldrich)
in 50% glycerol containing 250 μg/mL 40,6-diamidino-2-phenyl-
indole (DAPI) (Invitrogen) to visualize nuclei and cytoplasmic viral
factories. To determine if p28 co-localizes with HA-Ub or HA-K48-
Ub, cells infected with VVT7lacOI (VVT7) (MOI 5) were treated
with 10 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) (Fisher
Scientiﬁc) to induce T7 polymerase expression (Fuerst et al., 1987).
Cells were ﬁxed with 4% paraformalydehyde and permeabilized
with 1% NP-40 (Sigma-Aldrich). To detect p28, cells were stained
with rabbit anti-p28 (1:200), generously provided by Dr. M. Buller
(St. Louis University, Saint Louis, Missouri), or rabbit anti-Flag M2
(1:200) (Sigma-Aldrich), followed by staining with Alexa 546 goat
anti-rabbit (1:400) (Invitrogen) (Senkevich et al., 1995). To visua-
lize conjugated ubiquitin, cells were stained with anti-HA (1:200)
(Roche Diagnostics) followed by staining with goat anti-mouse
Alexa 488 (1:400) (Invitrogen). Cells were examined using a Zeiss
Axiovert scanning laser confocal microscope at 488 nm and
546 nm.
Flow cytometry
HeLa cells were transfected with 0.5 μg of pEGFP-C3 or 2 μg of
pEGFP-p28(IHDW), pEGFP-p28(ECTV), pEGFP-p28(1–152), pEGFP-
p28(153–242), pEGFP-p28(Δ44–51), pEGFP-p28(1–184), pEGFP-
p28(1–204), pEGFP-p28(C173S/C176S) with Lipofectamine accord-
ing to the manufacturers instructions (Invitrogen). Sixteen hours
post-transfection cells were divided in half and treated in the
absence or presence of the proteasome inhibitor MG132 (10 μM)
(Sigma-Aldrich) for 6 h. Cells were labeled with 0.2 μM tetra-
methylrhodamine ethyl ester (TMRE) (Invitrogen), washed and
resuspended in PBS containing 1% FBS and analyzed by two-color
ﬂow cytometry (Becton Dickinson) (Metivier et al., 1998). TMRE
ﬂuorescence was measured through the FL-2 channel equipped
with a 585-nm ﬁlter (42 nm band pass) and EGFP ﬂuorescence was
measured through the FL-1 channel equipped with a 489 nm ﬁlter
(42 nm band pass). The ﬂuorescence signals were acquired for
20,000 cells per sample at logarithmic gain and analysis was
performed using CellQuest software.
Ubiquitination
To determine ubiquitination, HeLa cells (2106) were infected
with VACV-HA-Ub at an MOI of 5 and transfected with 2 μg of the
following plasmids; pSC66-Flag-p28, pSC66-Flag-p28(1–152),
pSC66-p28(153–242), pSC66-Flag-p28(Δ44–51), pSC66-Flag-p28
(C173S/C176S), pSC66-Flag-p28(1–184), or pSC66-Flag-p28(1–
204). Cells were lysed in RIPA buffer containing 50 mM Tris–HCl,
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl and
EDTA-free protease inhibitors (Roche Diagnostic). p28 was immu-
noprecipitated with mouse anti-Flag M2 and western blotted with
rabbit anti-Flag (Sigma-Aldrich) to detect ubiquitination. To
further detect ubiquitination, cells were treated in the absence
or presence of MG132 (10 μM) for 6 h.
In vitro ubiquitination assay
HeLa cells (2.5106) were infected with VACVCop at an MOI of
5 and transfected with pSC66-Flag-p28, pSC66-Flag-p28(1–152),
pSC66-Flag-p28(153–242), pSC66-Flag-p28(Δ44–51), pSC66-Flag-
p28(C173S/C176S), pSC66-Flag-p28(1–184), or pSC66-Flag-p28
(1–204). Sixteen hours post-infection, immunoprecipitations were
performed using anti-Flag M2. Protein G beads were washed with
1% NP-40 lysis buffer and then additionally washed with (50 mM
Tris–HCl pH 7.5, 50 mM NaCl, 1 mM EDTA pH 8.0, 0.01% NP-40, 10%
glycerol) (Neznanov et al., 2008). The in vitro ubiquitination
protocol was followed manufacturer's instructions (BIOMOL Inter-
national). The ubiquitination reaction was carried out in ubiquiti-
nation buffer (0.4 mM Tris–HCl, pH 7.5), 10 U/mL inorganic
pyrophosphatase solution (Sigma-Aldrich), 1 mM DTT, 5 mM
MG-ATP, 50 nM E1, 1.25 μM E2 (UbcH3 or 5), and 1.25 μM
Biotinylated-Ub, and was directly added to the Flag-tagged pro-
teins immobilized at the protein G beads. The reaction was carried
out at 37 1C for 90 min and run on a SDS-page gel (Biorad).
The western blots were blocked in 1% BSA/TBST overnight and
blotted with Streptavidin-HRP (Pierce) 1:10,000 dilution to detect
ubiquitination.
Immunoblotting
Cell lysates were separated by SDS-PAGE and transferred to
polyvinylidene ﬂuoride membranes (GE Healthcare). Proteins
were detected using mouse anti-GFP (1:5000) (Covance), anti-I3L
(1:5000), provided by D. Evans (University of Alberta, Edmonton,
Canada), and beta-tubulin (1:1000) (ECM Biosciences) and pri-
mary antibodies were detected using donkey anti-mouse
(1:40000) (Jackson ImmunoResearch). Proteins were visualized
by enhanced chemiluminescence according to the manufacturer's
directions (GE Healthcare).
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